Scinovex
article Open AccessTop 1% cited

COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer

Surgical Endoscopy · 2015 · Vol. 30(8) · pp. 3210–3215
Charlotte L. DeijenSimone VelthuisAlice TsaiStella MavroveliElly S.M. de Lange–de KlerkColin SietsesJurriaan B. TuynmanAntonio M. LacyGeorge B. HannaH. Jaap Bonjer

Abstract

The difference in involvement of CRM between the two treatment strategies is thought to be in favour of the TaTME. TaTME is therefore expected to be superior to laparoscopic TME in terms of oncological outcomes in case of mid and low rectal carcinomas.

Colorectal Cancer Surgical TreatmentsColorectal Cancer Screening and DetectionColorectal and Anal CarcinomasMedicineTotal mesorectal excisionColorectal cancerMesorectumClinical endpointSurgeryRandomized controlled trialQuality of life (healthcare)Laparoscopic surgeryLaparoscopy

MeSH terms

Transanal Endoscopic SurgeryMargins of ExcisionAnal CanalCarcinomaHumansMesenteryNeoplasm Recurrence, LocalLaparoscopyQuality of LifeRectal NeoplasmsRectumDigestive System Surgical ProceduresSurvival RateDisease-Free SurvivalOrgan Sparing Treatments

Funding

  • Covidien
Citations
379
FWCI
15.23
field-weighted impact
References
31
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.